Literature DB >> 29102960

New Frontiers in Treating Uremic Metabolic Acidosis.

Denver Brown1, Michal L Melamed2.   

Abstract

Entities:  

Keywords:  acidosis; chronic kidney disease; chronic metabolic acidosis; uremia

Mesh：

Substances：

Year:  2017        PMID： 29102960      PMCID： PMC5753323          DOI： 10.2215/CJN.11771017

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  11 in total

1.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

2.  Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy.

Authors:  Ashutosh Mahajan; Jan Simoni; Simon J Sheather; Kristine R Broglio; M H Rajab; Donald E Wesson
Journal:  Kidney Int       Date:  2010-05-05       Impact factor: 10.612

3.  Effects of in vivo metabolic acidosis on midcortical bone ion composition.

Authors:  D A Bushinsky; J M Chabala; K L Gavrilov; R Levi-Setti
Journal:  Am J Physiol       Date:  1999-11

4.  Bicarbonate supplementation slows progression of CKD and improves nutritional status.

Authors:  Ione de Brito-Ashurst; Mira Varagunam; Martin J Raftery; Muhammad M Yaqoob
Journal:  J Am Soc Nephrol       Date:  2009-07-16       Impact factor: 10.121

5.  Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease.

Authors:  Joseph A Eustace; Brad Astor; Paul M Muntner; T Alp Ikizler; Josef Coresh
Journal:  Kidney Int       Date:  2004-03       Impact factor: 10.612

6.  Effects of oral sodium bicarbonate in patients with CKD.

Authors:  Matthew K Abramowitz; Michal L Melamed; Carolyn Bauer; Amanda C Raff; Thomas H Hostetter
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-07       Impact factor: 8.237

7.  Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD.

Authors:  David A Bushinsky; Thomas Hostetter; Gerrit Klaerner; Yuri Stasiv; Claire Lockey; Sarah McNulty; Angela Lee; Dawn Parsell; Vandana Mathur; Elizabeth Li; Jerry Buysse; Robert Alpern
Journal:  Clin J Am Soc Nephrol       Date:  2017-11-04       Impact factor: 8.237

8.  Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate.

Authors:  Nimrit Goraya; Jan Simoni; Chan-Hee Jo; Donald E Wesson
Journal:  Kidney Int       Date:  2014-04-02       Impact factor: 10.612

9.  The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway.

Authors:  J L Bailey; X Wang; B K England; S R Price; X Ding; W E Mitch
Journal:  J Clin Invest       Date:  1996-03-15       Impact factor: 14.808

10.  Persistent high serum bicarbonate and the risk of heart failure in patients with chronic kidney disease (CKD): A report from the Chronic Renal Insufficiency Cohort (CRIC) study.

Authors:  Mirela Dobre; Wei Yang; Qiang Pan; Lawrence Appel; Keith Bellovich; Jing Chen; Harold Feldman; Michael J Fischer; L L Ham; Thomas Hostetter; Bernard G Jaar; Radhakrishna R Kallem; Sylvia E Rosas; Julia J Scialla; Myles Wolf; Mahboob Rahman
Journal:  J Am Heart Assoc       Date:  2015-04-20       Impact factor: 5.501
View more
  1 in total

1.  Demarcation of Sepsis-Induced Peripheral and Central Acidosis with pH (Low) Insertion Cycle Peptide.

Authors:  Kelly E Henry; Aisling M Chaney; Veronica L Nagle; Haley C Cropper; Saghar Mozaffari; Gregory Slaybaugh; Keykavous Parang; Oleg A Andreev; Yana K Reshetnyak; Michelle L James; Jason S Lewis
Journal:  J Nucl Med       Date:  2020-01-31       Impact factor: 11.082
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.